A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System

August 13, 2013 updated by: Ellipse Technologies, Inc.

A Retrospective Multicenter Review of Early Onset Spinal Deformity Patients That Underwent Either a Primary or Revision Spinal Bracing Procedure With the Ellipse Technologies MAGEC Spinal Bracing and Distraction System

The purpose of this study is to determine the safety profile and probable benefit of the Ellipse Technologies Inc. MAGEC System in subjects with early onset spinal deformity associated with thoracic insufficiency syndrome.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

54

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11559
        • University of Cairo Public Hospital
      • Helsinki, Finland, 00029
        • University of Helsinki
      • Turku, Finland
        • Turku University Hospital
      • Hong Kong, Hong Kong
        • University of Hong Kong
      • Bologna, Italy
        • Instituto Rizzoli
      • Rome, Italy
        • Bambin Gesù
      • Auckland, New Zealand
        • Starship Children's Hospital
      • Ankara, Turkey
        • Hacettepe University Hospital
      • Ankara, Turkey
        • Ankara Gazi Universitesi Hastanesi
      • Istanbul, Turkey, 34403
        • Florence Nightingale Hospital Ortopedi Bolumu
      • Istanbul, Turkey
        • Marmara Üniversitesi Eğt.ve Arş.Hastanesi
      • Izmir, Turkey
        • Ege Sağlık Hastanesi
      • Cardiff, United Kingdom, CF 14 4XW
        • University Hospital of Wales
      • London, United Kingdom
        • The Harley Street Clinic
    • Middlesex
      • Stanmore, Middlesex, United Kingdom, HA7 4LP
        • Royal National Orthopaedic Hospital NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients worldwide implanted with the Ellipse Technologies Spinal Bracing and Distraction System (Invitation to Volunteer Non-Probability Sample).

Description

Inclusion Criteria:

  • Early onset spinal deformity with any etiology
  • Cobb angle measurement of 30 degrees or greater at the time of primary surgery
  • Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery
  • Age less than 11 years old at the time of MAGEC implant
  • Implanted with the MAGEC system as either a primary or secondary revision spinal bracing procedure
  • Patient has been implanted for a minimum of 6 months
  • Patient signs informed consent for the use of their personal private data

Exclusion Criteria:

  • Patient declines to sign informed consent for the use of their personal private data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
MAGEC Implant
All patients implanted with the MAGEC System will be reviewed for inclusion into this retrospective study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cobb Angle
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured in Degrees
Baseline and 6, 12, 18 and 24 Months Postoperatively
Change in Thoracic Spine Height
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured in millimeters (mm)
Baseline and 6, 12, 18 and 24 Months Postoperatively
Change in Space Available for Lung
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured as a percentage (%)
Baseline and 6, 12, 18 and 24 Months Postoperatively
Ocurrence of Procedure-Related Complications
Time Frame: Baseline, Device Implant and 6, 12, 18 and 24 Months Postoperatively
Baseline, Device Implant and 6, 12, 18 and 24 Months Postoperatively
Occurrence of Adverse Events
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Baseline and 6, 12, 18 and 24 Months Postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Coronal Balance
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured in millimeters (mm)
Baseline and 6, 12, 18 and 24 Months Postoperatively
Change in Sagittal Balance
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured in millimeters (mm)
Baseline and 6, 12, 18 and 24 Months Postoperatively
Occurrence of Subsequent surgical interventions following initial implantation
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Baseline and 6, 12, 18 and 24 Months Postoperatively
Change in Weight
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
Measured in kilograms (kg)
Baseline and 6, 12, 18 and 24 Months Postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Behrooz A Akbarnia, MD, San Diego Center for Spinal Disorders

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

September 19, 2012

First Submitted That Met QC Criteria

October 26, 2012

First Posted (Estimate)

October 30, 2012

Study Record Updates

Last Update Posted (Estimate)

August 15, 2013

Last Update Submitted That Met QC Criteria

August 13, 2013

Last Verified

August 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PR0056

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thoracic Insufficiency Syndrome

Subscribe